Jungo, Katharina Tabea
Deml, Michael J.
Schalbetter, Fabian
Moor, Jeanne
Feller, Martin
Lüthold, Renata Vidonscky
Huibers, Corlina Johanna Alida
Sallevelt, Bastiaan Theodoor Gerard Marie
Meulendijk, Michiel C
Spruit, Marco
Schwenkglenks, Matthias
Rodondi, Nicolas
Streit, Sven
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (407440_167465, 407440_167465, 407440_167465)
Article History
Received: 15 August 2023
Accepted: 23 February 2024
First Online: 18 March 2024
Change Date: 2 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12913-024-10896-2
Declarations
:
: The ethics committee of the canton of Bern (Switzerland) and the Swiss regulatory authority (Swissmedic) approved the study protocol of the OPTICA trial (BASEC ID: 2018–00914) including the conduct of this mixed-methods evaluation. All study participants provided informed consent to participate in the trial. All methods were performed in accordance with the relevant guidelines and regulations (e.g., declaration of Helsinki).
: Not required.
: The authors declare no competing interests.